Production & Manufacturing

The final stages of the pharmaceutical manufacturing process, where the therapeutic product is filled into its primary container and prepared for delivery, have long been dominated by high-speed lines designed for millions of identical doses. However, the emergence of...

The development of Chimeric Antigen Receptor T-cell (CAR-T) therapy has provided a new and powerful tool for the treatment of hematological malignancies, offering hope to patients who have exhausted all other therapeutic options. However, the logistical and technical challenge...

The rapid expansion of the gene therapy sector has created a critical challenge in the production of viral vectors, the specialized vehicles used to deliver genetic material to target cells. As more therapies move from early-phase clinical trials toward...

The logistical and technical complexity of producing personalized medicines has reached a point where traditional batch testing methods are no longer sufficient to meet the needs of a growing patient population. In conventional pharmaceutical production, a product is manufactured...

A new research project from the Johns Hopkins Bloomberg School of Public Health has identified a pharmaceutical industry practice that could be a significant factor in global health disparities. Published in PLOS Global Public Health on July 07, 2026,...

Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd, has officially commissioned an advanced integrated Antibody–Drug Conjugate (ADC) GMP manufacturing site in Dharwad. Announced on 25 June 2026, the facility was specifically engineered to satisfy the rigorous global regulatory...

CPHI Milan 2026, recognized as a premier global gathering for the pharmaceutical industry, has announced the introduction of four new specialist zones for pharma at its upcoming event. Scheduled for October 6-8, 2026, at the Fiera Milan exhibition centre...